The next frontier in GLP-1 drug development GLP-1 medications have already reshaped obesity management, but research pipelines suggest that what we have today is just the beginning
Inclusion criteria often blended new and prevalent drug users, introducing immortal time bias
For anyone following this field, the existing evidence offers a compelling scientific rationale for that investment, while demanding the intellectual honesty to acknowledge how much remains unknown
Its a uniquely frustrating and pervasive issue, one that our team sees come up constantly in discussions about performance, recovery, and longevity research
Reason for admission Current diagnosis Vital signs Oxygen/Ventilator support Current concerns or emergencies Keep information brief and focused B BACKGROUND Purpose: Provide relevant clinical history
Marked individual variability in the levels of trimethylselenonium ion in human urine determined by HPLC/ICPMS and HPLC/vapor generation/ICPMS